The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease
Open accessAbstract
Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor known to induce expression of a variety of cytoprotective and detoxification genes. Several of the genes commonly regulated by Nrf2 have been implicated in protection from neurodegenerative conditions. Work from several laboratories has uncovered the potential for Nrf2-mediated transcription to protect from neurodegeneration resulting from mechanisms involving oxidative stress. For this reason, Nrf2 may be considered a therapeutic target for conditions that are known to involve free radical damage. Because common mechanisms of neurodegeneration, such as mitochondrial dysfunction and build-up of reactive oxygen species, are currently being uncovered, targeting Nrf2 may be valuable in combating conditions with variable causes and etiologies. Most effectively to target this protein in neurodegenerative conditions, a description of the involvement of Nrf2 and potential for neuroprotection must come from laboratory models. Herein, we review the current literature that suggests that Nrf2 may be a valuable therapeutic target for neurodegenerative disease, as well as experiments that illustrate potential mechanisms of protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 2×
“Keap1 is a known repressor of Nrf2 activity (21), and E3 ligase, for Nrf2 (68).”
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
The Biologic Clock: The Mitochondria?
HARMAN, D. (1972) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1972.tb00787.x · Cited by 1,991
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“Keap1 is a known repressor of Nrf2 activity (21), and E3 ligase, for Nrf2 (68).”
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
(2002) · PubMed · Cited by 1,190
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 1×
“Furthermore, knocking down expression of the mutated allele in astrocytes leads to diminished microglial activation and overall disease progression (67).”
Trends in oxidative aging theories
Muller, F. L., Lustgarten, M. S., Jang, Y., Richardson, A., & Van Remmen, H. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.034 · Cited by 1,053
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., & Biswal, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421146 · Cited by 991
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., & Yamamoto, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00640.x · Cited by 816
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796
Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., & Lozniewski, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112203099 · Cited by 795
Lee, J.-M., Calkins, M. J., Chan, K., Kan, Y. W., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211558200 · Cited by 786
Self-citationShih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 785
Self-citationKwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 660
What is the role of protein aggregation in neurodegeneration?
Ross, C. A., & Poirier, M. A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1742 · Cited by 604
Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
Kraft, A. D., Johnson, D. A., & Johnson, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-03.2004 · Cited by 541
Self-citationDirect and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
Nrf2, a multi‐organ protector?
Lee, J., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J., & Johnson, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2591hyp · Cited by 532
Self-citationBloom, D. A., & Jaiswal, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307633200 · Cited by 525
Rushmore, T. H., & Pickett, C. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77351-1 · Cited by 521
Stewart, D., Killeen, E., Naquin, R., Alam, S., & Alam, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209195200 · Cited by 463
Shih, A. Y., Li, P., & Murphy, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4014-05.2005 · Cited by 413
Dopamine turnover and glutathione oxidation: implications for Parkinson disease.
Spina, M. B., & Cohen, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1398 · Cited by 395
Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05039.x · Cited by 393
Bioenergetic and oxidative stress in neurodegenerative diseases
Bowling, A. C., & Beal, M. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00055-b · Cited by 366
Zipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phase II inducers
Satoh, T., Okamoto, S.-I., Cui, J., Watanabe, Y., Furuta, K., Suzuki, M., Tohyama, K., & Lipton, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505723102 · Cited by 341
A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
Barbeito, L. H., Pehar, M., Cassina, P., Vargas, M. R., Peluffo, H., Viera, L., Estévez, A. G., & Beckman, J. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.003 · Cited by 327
Self-citationLee, J.-M., Shih, A. Y., Murphy, T. H., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305204200 · Cited by 308
Self-citationThe Nrf2–ARE cytoprotective pathway in astrocytes
Vargas, M. R., & Johnson, J. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001094 · Cited by 291
Self-citationDietary factors, hormesis and health
Mattson, M. P. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.08.004 · Cited by 291
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273
Nrf2-mediated protection against 6-hydroxydopamine
Jakel, R. J., Townsend, J. A., Kraft, A. D., & Johnson, J. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.131 · Cited by 250
Self-citationZipper, L. M. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg083 · Cited by 249
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247
Self-citationDietary chemopreventive compounds and ARE/EpRE signaling
Chen, C., & Kong, A.-N. T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.015 · Cited by 241
Pehar, M., Cassina, P., Vargas, M. R., Castellanos, R., Viera, L., Beckman, J. S., Estévez, A. G., & Barbeito, L. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02357.x · Cited by 228
Self-citationLee, J.-M., Hanson, J. M., Chu, W. A., & Johnson, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100734200 · Cited by 228
Self-citationLi, J., Johnson, D., Calkins, M., Wright, L., Svendsen, C., & Johnson, J. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi027 · Cited by 227
Self-citationTranscription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Zhao, X., Sun, G., Zhang, J., Strong, R., Dash, P. K., Kan, Y. W., Grotta, J. C., & Aronowski, J. (2007) · Stroke · doi:10.1161/strokeaha.107.486506 · Cited by 227
Neuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218
The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
Sykiotis, G. P., Habeos, I. G., Samuelson, A. V., & Bohmann, D. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834136f2 · Cited by 214
Zhang, Y. S., Kolm, R. H., Mannervik, B., & Talalay, P. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1106 · Cited by 208
Carbonyl Toxicology and Alzheimer's Disease
Picklo, M. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194
Li, J., Lee, J.-M., & Johnson, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109380200 · Cited by 193
Self-citationIn vivo modulation of the Parkinsonian phenotype by Nrf2
Burton, N. C., Kensler, T. W., & Guilarte, T. R. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.019 · Cited by 187
Vargas, M. R., Pehar, M., Cassina, P., Beckman, J. S., & Barbeito, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03742.x · Cited by 180
Self-citationKarapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1089-1099.2005 · Cited by 173
Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2
Alam, J., Killeen, E., Gong, P., Naquin, R., Hu, B., Stewart, D., Ingelfinger, J. R., & Nath, K. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00376.2002 · Cited by 167
Trinh, K., Moore, K., Wes, P. D., Muchowski, P. J., Dey, J., Andrews, L. A., & Pallanck, L. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4778-07.2008 · Cited by 165
Axis determination by inhibition of Wnt signaling in Xenopus
Itoh, K., & Sokol, S. Y. (1999) · Genes & Development · doi:10.1101/gad.13.17.2328 · Cited by 163
Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice
Li, J., Stein, T. D., & Johnson, J. A. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00209.2003 · Cited by 161
Self-citationJohnson, D. A., Andrews, G. K., Xu, W., & Johnson, J. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00913.x · Cited by 157
Self-citationMinghetti, L., Carnevale, D., & Simone, R. D. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783399193 · Cited by 146
Vargas, M. R., Pehar, M., Cassina, P., Palma, L. M., Thompson, J. A., Beckman, J. S., & Barbeito, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501920200 · Cited by 146
Self-citationPehar, M., Vargas, M. R., Robinson, K. M., Cassina, P., Díaz‐Amarilla, P., Hagen, T. M., Radí, R., Barbeito, L., & Beckman, J. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0823-07.2007 · Cited by 145
Self-citationKraft, A. D., Lee, J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04019.x · Cited by 108
Self-citationNrf2 promotes neuronal cell differentiation
Zhao, F. L., Wu, T., Lau, A., Jiang, T., Huang, Z., Wang, X.-J., Chen, W., Wong, P. K., & Zhang, D. D. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.029 · Cited by 103
The Role of Autophagy in Age-Related Neurodegeneration
McCray, B. A., & Taylor, J. P. (2007) · Neurosignals · doi:10.1159/000109761 · Cited by 92
Haristoy, X., Angioï-Duprez, K., Duprez, A., & Lozniewski, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3982-3984.2003 · Cited by 88
Calkins, M. J., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq072 · Cited by 87
Self-citationKraft, A. D., Resch, J. M., JOHNSON, D., & JOHNSON, J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.026 · Cited by 84
Self-citationParkinson's Disease: From Molecular Pathways in Disease to Therapeutic Approaches
Thomas, B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2697 · Cited by 74
Targeting Oxidative Stress for Neuroprotection
Linseman, D. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2236 · Cited by 56
Jakel, R. J., Kern, J. T., Johnson, D. A., & Johnson, J. A. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi241 · Cited by 55
Self-citationHalliwell, B. B. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2007 · Cited by 53
Structural analysis of the complex of Keap1 with a prothymosin α peptide
Padmanabhan, B., Nakamura, Y., & Yokoyama, S. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108004995 · Cited by 50
NF-E2-related factor 2 activation in PC12 cells: its protective role in manganese-induced damage
Li, H., Wu, S., Shi, N., Lin, W. J., You, J., & Zhou, W. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0625-6 · Cited by 37
The Nrf2 pathway as a potential therapeutic target for Huntington disease
Escartin, C., & Brouillet, E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.009 · Cited by 10
The Nrf2-ARE pathway: A potential therapeutic target for neurodegenerative diseases
Johnson, J. A., Johnson, D. A., Lee, J., Li, J., Kraft, A. D., Calkins, M. J., & Jakel, R. J. (2007) · International Congress Series · doi:10.1016/j.ics.2006.10.026 · Cited by 9
Self-citation
Cited by
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways
Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150014 · Cited by 1,200
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 790
Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01204-10 · Cited by 759
Metadata
- Authors
- Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J.-M., Li, J., & Johnson, J. A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2009-03
- Volume
- 11
- Issue
- 3
- Pages
- 497-508
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2073688363
- Cited by
- 438
- References
- 81
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.